171 related articles for article (PubMed ID: 37824217)
1. Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1.
Zhong Q; Wang HG; Yang JH; Tu RH; Li AY; Zeng GR; Zheng QL; Yu Liu Z; Shang-Guan ZX; Bo Huang X; Huang Q; Li YF; Zheng HL; Lin GT; Huang ZN; Xu KX; Qiu WW; Jiang MC; Zhao YJ; Lin JX; Huang ZH; Huang JM; Li P; Xie JW; Zheng CH; Chen QY; Huang CM
Adv Sci (Weinh); 2023 Nov; 10(32):e2301977. PubMed ID: 37824217
[TBL] [Abstract][Full Text] [Related]
2. Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting
Dong X; Song S; Li Y; Fan Y; Wang L; Wang R; Huo L; Scott A; Xu Y; Pizzi MP; Ma L; Wang Y; Jin J; Zhao W; Yao X; Johnson RL; Wang L; Wang Z; Peng G; Ajani JA
Gut; 2022 Mar; 71(3):467-478. PubMed ID: 33785559
[TBL] [Abstract][Full Text] [Related]
3. Growth arrest-specific gene 1 is downregulated and inhibits tumor growth in gastric cancer.
Wang H; Zhou X; Zhang Y; Zhu H; Zhao L; Fan L; Wang Y; Gang Y; Wu K; Liu Z; Fan D
FEBS J; 2012 Oct; 279(19):3652-3664. PubMed ID: 22846196
[TBL] [Abstract][Full Text] [Related]
4. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
5. WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals.
Kann M; Bae E; Lenz MO; Li L; Trannguyen B; Schumacher VA; Taglienti ME; Bordeianou L; Hartwig S; Rinschen MM; Schermer B; Benzing T; Fan CM; Kreidberg JA
Development; 2015 Apr; 142(7):1254-66. PubMed ID: 25804736
[TBL] [Abstract][Full Text] [Related]
6. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
7. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
9. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
10. GAS1 induces cell death through an intrinsic apoptotic pathway.
Zarco N; González-Ramírez R; González RO; Segovia J
Apoptosis; 2012 Jun; 17(6):627-35. PubMed ID: 22311470
[TBL] [Abstract][Full Text] [Related]
11. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract][Full Text] [Related]
12. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
[No Abstract] [Full Text] [Related]
13. DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.
Dai L; Zhuang L; Zhang B; Wang F; Chen X; Xia C; Zhang B
Int J Mol Sci; 2015 Dec; 16(12):28510-22. PubMed ID: 26633375
[TBL] [Abstract][Full Text] [Related]
14. Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma.
Li Q; Qin Y; Wei P; Lian P; Li Y; Xu Y; Li X; Li D; Cai S
Mol Cancer Res; 2016 Sep; 14(9):830-40. PubMed ID: 27401611
[TBL] [Abstract][Full Text] [Related]
15. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
16. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
17. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
[TBL] [Abstract][Full Text] [Related]
18. WT1 is involved in the Akt-JNK pathway dependent autophagy through directly regulating Gas1 expression in human osteosarcoma cells.
Mo H; He J; Yuan Z; Mo L; Wu Z; Lin X; Liu B; Guan J
Biochem Biophys Res Commun; 2016 Sep; 478(1):74-80. PubMed ID: 27453337
[TBL] [Abstract][Full Text] [Related]
19. Gas1 reduces Ret tyrosine 1062 phosphorylation and alters GDNF-mediated intracellular signaling.
López-Ramírez MA; Domínguez-Monzón G; Vergara P; Segovia J
Int J Dev Neurosci; 2008 Aug; 26(5):497-503. PubMed ID: 18394855
[TBL] [Abstract][Full Text] [Related]
20. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway.
Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J
Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
